Rayvolve
AZmed · Decision date May 12, 2026
What did the FDA decide?
FDA records K260378 as a 510(k) premarket notification, with a decision dated May 12, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- May 12, 2026
Regulatory record facts
- Identifier
- K260378
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- AZmed
- Product code
- QBS
- Decision code
- SESE
- Decision date
- May 12, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Radiological Computer Assisted Detection/Diagnosis Software For Fracture.
FDA decision timeline
K260378 received
Application receipt date recorded by FDA.
K260378 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code QBS
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
CINA-AneurysmK262062 | AVICENNA.AI | 510(k) clearance | Oct 20, 2026 | FDA |
Rayvolve AZchestK261378 | AZmed | 510(k) clearance | Aug 28, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
AZmed
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Paris
Sources and methodology
- Original FDA record: K260378
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
